Dollars for Docs Update: Now With 12 Companies, More Than $760 Million in Payments
by Dan Nguyen, Charles Ornstein and Tracy Weber, ProPublica
Sept. 7
Drug companies have long kept secret details of the payments they make to doctors and other health professionals for promoting their drugs. But 12 companies have begun publicizing the information. ProPublica pulled their disclosures into a database so patients can search for their doctor.
Look up your doctor »
Also Check Out
With Our Dollars for Docs Update Coming, Drug Companies Defend ‘Interactions’ With Physicians
by Charles Ornstein and Tracy Weber, ProPublica, Sep. 7, 11:48 a.m.
As ProPublica gets ready to refresh its Dollars for Docs database listing payments from drug companies to hundreds of thousands of doctors, the Pharmaceutical Research and Manufacturers of America says paid physician speakers play a critical role in improving patient care.
Sep 09, 2011 09:39AM
Fewer Harvard faculty speak on pharma's behalf
Harvard doctors and researchers aren't as active on the pharma speaking circuit these days. As the Harvard Crimson reports, based on an analysis of ProPublica data, Massachusetts doctors collected fewer speaking fees from drugmakers in recent quarters. And some have backed out of speakers' bureaus altogether.
As the Boston Globe reports, Eli Lilly's ($LLY) speaker fees in Massachusetts dropped to $866,910 in 2010 from $1.6 million in 2009. GlaxoSmithKline's ($GSK) speaking fees fell to $884,850 from $1.2 million..........
This blog is all about current FDA approved drugs to treat the hepatitis C virus (HCV) with a focus on treating HCV according to genotype, using information extracted from peer-reviewed journals, liver meetings/conferences, and interactive learning activities.
Risk Of Developing Liver Cancer After HCV Treatment
- Home
- Newly Diagnosed With Hep C? Or Considering Treatment?
- All FDA Approved Drugs To Treat Hepatitis C
- Hepatitis C Genotypes and Treatment
- Mavyret (glecaprevir/pibrentasvir)
- Vosevi (Sofosbuvir/Velpatasvir/Voxilaprevir)
- Epclusa® (Sofosbuvir/Velpatasvir)
- Harvoni® (Ledipasvir/Sofosbuvir)
- VIEKIRA XR/VIEKIRA Pak
- Zepatier(Elbasvir/Grazoprevir)
- Cure - Achieving sustained virologic response (SVR) in hepatitis C
- HCV Liver Fibrosis
- FibroScan® Understanding The Results
- HCV Cirrhosis
- Staging Cirrhosis
- HCV Liver Cancer
- Risk Of Developing Liver Cancer After HCV Treatment
- Treating Elderly HCV Patients
- Fatty Liver Disease: NAFLD/NASH
- Current research articles on ailments that may be related to HCV
- Is There A Natural Way To Improve Liver Fibrosis?
- Can Food Or Herbs Interact With Conventional Medical Treatments?
No comments:
Post a Comment